Latest news
LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $121 - MoomooMoomoo · Sun, 09 Aug 2026 07:12:24 GMTContext downgraded to Market Perform from Outperform at LifeSci Capital - tipranks.comtipranks.com · Thu, 06 Aug 2026 23:15:10 GMTLifeSci Capital Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $6 - MoomooMoomoo · Wed, 29 Jul 2026 20:31:00 GMT